Beranda › Kanker Saluran Empedu (Kolangiokarsinoma) › California

Uji klinis Kanker Saluran Empedu (Kolangiokarsinoma) di California

20 studi untuk Kanker Saluran Empedu (Kolangiokarsinoma) mencari peserta di lokasi di California.

Kota di California

Teks studi resmi (Bahasa Inggris)

A Study of PHST001 in Advanced Solid Tumors

Precision NextGen Oncology & Research Center, Beverly Hills
USC Norris Comprehensive Cancer Center, Los Angeles
Stanford University School of Medicine, Palo Alto

Menerima pesertaFase 1

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 5 Okt 2026 · NCT06840886

A Study to Select a Dose Regimen (Part A) and to Investigate Overall Survival (Part B) With Nanvuranlat Compared With Physician's Best Choice in Participants Aged 18 Years or Older With Biliary Tract Cancer

City of Hope (Site 107), Duarte
University of California at Irvine (Site 101), Orange
UCLA Medical Center (Site 117), Santa Monica

Menerima pesertaFase 3

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 29 Sep 2026 · NCT07265674

A Study of LY4337713 in Participants With FAP-Positive Solid Tumors

Hoag Memorial Hospital Presbyterian, Newport Beach
Stanford University Medical Center, Stanford

Menerima pesertaFase 1

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07213791

A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors

START Los Angeles, Los Angeles

Menerima pesertaFase 1/2

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07488676

Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors

Stanford University, Palo Alto

Menerima pesertaFase 1/2

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 8 Sep 2026 · NCT05732831

Pilot Comparing ctDNA IDV vs. SPV Sample in Pts Undergoing Biopsies for Hepatobiliary and Pancreatic Cancers

Chao Family Comprehensive Cancer Center, University of California, Irvine, Orange

Menerima peserta

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 31 Agu 2026 · NCT05497531

AB801 in Combination With Chemotherapy and Immunotherapy for the Treatment of Patients With Borderline Resectable, Locally Advanced or Metastatic Cholangiocarcinoma or Pancreatic Cancer

UCLA / Jonsson Comprehensive Cancer Center, Los Angeles

Menerima pesertaFase 1

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 20 Agu 2026 · NCT07619313

Olutasidenib DDI Study in Patients With IDH1 Mutation Positive Malignancies

UCI Irvine Health, Orange

Menerima pesertaFase 4

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 11 Agu 2026 · NCT07486713

Pressurized Intraperitoneal Aerosolized Nab-Paclitaxel in Combination With Gemcitabine and Cisplatin for the Treatment of Biliary Tract Cancer Patients With Peritoneal Metastases

City of Hope Medical Center, Duarte

Menerima pesertaFase 1

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 3 Agu 2026 · NCT05285358

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

Precision NextGen Oncology & Research Center, Beverly Hills
UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco
University of California Los Angeles Rheumatology, Westwood, Los Angeles

Menerima pesertaFase 2

Usia 8 ke atas · Semua jenis kelamin · Diperbarui 27 Jul 2026 · NCT05503797

Combination of GNS561 and Trametinib in Patients With Advanced KRAS Mutated Cholangiocarcinoma

USC Norris Comprehensive Cancer Center, Los Angeles
LACN Aneheim Flagship Office, Los Angeles

Menerima pesertaFase 1/2

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 13 Jul 2026 · NCT05874414

A First in Human Study of PLT012 in Participants With Solid Tumor Cancers

USC Norris Comprehensive Cancer Center, Los Angeles

Menerima pesertaFase 1

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 7 Jul 2026 · NCT07337525

A Noninvasive and Screening miRNA Signature for Gastrointestinal Cancer

City of Hope Nat Medical Ctr, Duarte

Menerima pesertaStudi observasionalSukarelawan sehat diterima

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 7 Jul 2026 · NCT07224750

An Exosome-Based Liquid Biopsy for the Differential Diagnosis of Primary Liver Cancer

City of Hope Medical Center, Duarte

Menerima pesertaStudi observasional

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 7 Jul 2026 · NCT06342414

A Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors

USC Norris Comprehensive Cancer Center, Los Angeles

Menerima pesertaFase 1/2

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Jul 2026 · NCT07169734

Locally ablatIVe thErapy for oLigo-progressive gastrOintestiNal maliGnancies (LIVELONG)

University of California, Davis Comprehensive Cancer Center, Sacramento

Menerima peserta

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Jul 2026 · NCT06101277

A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation

Cedars-Sinai Medical Center, Los Angeles

Menerima pesertaFase 1

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 29 Jun 2026 · NCT07458347

A Study of MGC028 in Participants With Advanced Solid Tumors

UCSF - Helen Diller Family Cancer Center, San Francisco

Menerima pesertaFase 1

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 27 Apr 2026 · NCT06723236

REGULUS: MRI-guided Adaptive SABR for Liver Cancers

Stanford University, Palo Alto

Menerima pesertaFase 2

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 9 Feb 2026 · NCT07223307

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Massive Bio SYNERGY-AI site, Duarte
Massive Bio SYNERGY-AI site, Irvine
Massive Bio SYNERGY-AI site, La Jolla
dan 3 lainnya

Menerima pesertaStudi observasional

Semua usia · Semua jenis kelamin · Diperbarui 28 Okt 2025 · NCT03452774

Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.